|

TH9619 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • One-carbon Therapeutics AB1

Indications

  • Gastrooesophageal Junction Cancer1
  • Squamous Cell Carcinoma of Head and Neck1
  • Non-small Cell Lung Cancer (NSCLC)1
  • Colorectal Cancer (CRC)1
  • Solid Tumor1

Other1 trial

Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.